Funding opportunities for COVID-19 research available to investigators

Research Development at Penn State College of Medicine maintains a list of funding opportunities for investigators interested in research projects related to COVID-19.

Updated Aug. 8, 2022

Note regarding human subjects research

In order to reduce any additional personal contact between individuals, certain guidelines are in place for clinical research. See details on the University’s requirements for human subjects research here.

Department of Health and Human Services

• Added March 1, 2022: AHRQ Special Emphasis Notice (NOT-HS-22-010) – AHRQ announces interest in health services research on health system and healthcare professional responsiveness to COVID-19. The Agency encourages research teams to submit applications using AHRQ’s standing R18, R03, and R01 funding mechanisms (PA-18-793, PA-18-794, PA-18-795). Applications responding to this SEN should be submitted on regular application receipt dates identified in the respective Funding Opportunity Announcement and will be reviewed by AHRQ standing study sections. (release date: February 17, 2022; expiration date: February 14, 2025)

National Institutes of Health (NIH)

• Added Aug. 25, 2021: Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations (NOT-MH-21-330). (first available due date: Oct. 5, 2021; expiration date: Sept. 8, 2024)
• Added June 30, 2021: Forecasted Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed). (first estimated application due date: Oct. 15, 2021)
• Added June 30, 2021: NOT-AI-21-057: Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide. (first available due date Sept. 7, 2021; expiration date May 8, 2024)
• Added April 20, 2021: Notice of Special Interest (NOSI) The National Institute on Drug Abuse (NIDA) announced the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus. NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders. Applications in response to this NOSI must be submitted using the following targeted funding opportunities: PA-18-935 and PA-20-272. (rolling deadlines through March 31, 2022)
• Added April 16, 2021: NOT-DA-21-041: Notice of Special Interest (NOSI) Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus. In order to rapidly improve our understanding of the risks, prevalence and available control measures for SARS-CoV-2 in substance using and/or HIV-affected populations, NIDA is encouraging the submission of applications for Administrative Supplements or Competitive Revisions to active grants to address several specific research areas of interest outlined in this NOSI. (Rolling deadlines through March 31, 2022)
• Added March 3, 2021: NOT-AG-21-016 Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration (rolling deadlines from June 5, 2021, to May 8, 2023)
• Added Feb. 19, 2021: Notice of Special Interest (NOSI) – NOT-AG-21-015: Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19) (deadline May 8, 2023)
• Added Feb. 19, 2021: Notice of Special Interest (NOSI) – NOT-DA-21-011: Effects of smoking and vaping on the risk and outcome of COVID-19 infection (deadline Sept. 8, 2024)
• Added Feb. 19, 2021: Notice of Special Interest (NOSI) – NOT-DA-21-018: Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders (deadline Sept. 8, 2024)
• Added Feb. 19, 2021: Notice of Special Interest (NOSI) – NOT-DE-21-001: NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19) (deadline May 8, 2023)
• Added Nov. 8, 2020: NOT-DA-20-084 – Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection (deadline Sept. 8, 2024)
• Added Oct. 26, 2020: NOT-HD-20-031 – Notice of Special Interest (NOSI): Research on Rehabilitation Needs Associated with the COVID-19 Pandemic (deadline May 8, 2023)
• Added May 4, 2020: National Institute of Biomedical Imaging and Bioengineering Point-of-Care Technology Research Network Fast-Track Program for COVID-19 Test Development and Distribution: Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing (NIBIB) (rolling deadline)
• Updated May 1, 2020: NOT-DK-20-026 Notice of Additional Activity Code Accepted for “NOT-DK-20-018, Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK”
• Added May 1, 2020: NOT-TR-20-018 Notice of Change in Eligibility and Activity Codes for NOT-TR-20-011, Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need
• Added April 27, 2020: NOT-DC-20-006 Notice of Eligibility Change for NIDCD Urgent Competitive Revisions and Administrative Supplements for Research on COVID-19
• Added April 27, 2020: PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional) (deadline Oct. 25, 2022)
• Added April 27, 2020: PA-20-135 Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) (deadline March 10, 2023)

Resources

• Added March 26, 2020: Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding – includes a video update on common questions, FAQs on flexibilities for the research community, funding opportunities and more
• Added March 23, 2020: NIAID’s Multi-Pronged Response to the COVID-2019 Outbreak
• Added March 23, 2020: NIH Fogarty International Center Coronavirus news, funding and resources for global health researchers (resource)

National Science Foundation: RAPID Research on Coronavirus (COVID-19)

• Added March 27, 2020: NSF 20-065 Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19
• Added March 23, 2020: NSF 20-052 Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) (also see NSF 20-052 FAQs)
• Added March 23, 2020: NSF 20-055 Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)

Resources

• NSF Supporting Research to Address Coronavirus Disease (blog)

Other Funders

Note: Investigators with interest in corporate funding should contact Corporate and Foundation Relations before proceeding with any application process.

• Added April 27, 2020: Rapidly Emerging Antiviral Drug Discovery Initiative (READDI)
• Added April 15, 2020: Allen Institute for AI COVID-19 Open Research Dataset Challenge (CORD-19)
• Added April 15, 2020: XPRIZE Pandemic Alliance: Fight COVID-19
• Added April 13, 2020: Google Cloud Research Credits

Learn more

For details, contact researchdevelopment@pennstatehealth.psu.edu.

If you're having trouble accessing this content, or would like it in another format, please email the Penn State College of Medicine web department.